Location: following prior palpation, patient-oriented application (biofeedback).
Energy: up to 2.5 bar
Interval: 1–2 times per week
Frequency: up to 10 Hz
Impulses: 2,000–4,000 impulses per session
Sessions: 3–8 treatments
Location: following prior palpation, patient-oriented focus application (biofeedback).
Energy: EFD: up to 0.30 mJ/mm²
Interval: 1 to 2 times per week
Frequency: FSW 3–5 Hz
Impulses: 2,000–4,000 per session, 200–400 impulses per myofascial trigger point (MTrP)
Sessions: 3–8 treatments
Muscles and fascia are well-innervated and are frequently the cause of acute and chronic pain. Consequently, myofascial tissue must be specifically examined in musculoskeletal conditions and accounted for in classification (according to ICD-10). A myofascial trigger point (MTrP) is a circumscribed structure within the muscle or connective tissue that triggers pain and is involved in a musculoskeletal pain process.
Due to their precise application even in deep tissue layers, focused shockwaves are utilized in both the diagnosis and therapy of myofascial conditions and trigger points.
Muscles and fascia represent an anatomical and functional unit, which is also treated collectively.
ESWT is also indicated for connective tissue disorders.
ICD-10: M79.1 for myofascial pain syndrome, and additional local or regional pain, e.g., lumbar-sciatica M54.4
Myofascial pain syndrome, myogelosis, muscle contracture, muscle trigger points, myofascial trigger points, fascial shortening, fascial dysfunction.
Acute and chronic skeletal muscle injuries
Acute and chronic overload, overstretching, direct trauma, non-physiological loading of the musculoskeletal system
In combination with enthesopathies, incorrect loading (e.g., poor statics, muscular imbalances), radiculopathies, arthrogenic dysfunctions and irritations, internal organ diseases, endocrine diseases, psychosomatic reactive changes
Localized pain with involvement of the musculoskeletal system, localized hypersensitivity, referred pain (frequent pseudoradicular diffusion), dysesthesia, pain upon tension and stretching, joint pain, tendon pain, regional pain (e.g., headaches), muscle shortening, muscle hardening, reduced strength, coordination disturbances, vegetative symptoms.
Basic diagnosis: clinical neurological-orthopedic examination.
Clinical examination: mobility, sensorimotor function, specific stretching tests.
Palpation is the gold standard in the clinical examination of muscles and fascia, including the diagnosis of trigger points.
Diagnosis with ESWT:
With feedback and according to diagnostic criteria (e.g., “recognition”, “referred pain”).
Diagnostic imaging:
If necessary, orientative ultrasound at the treatment site for local diagnosis. Ultrasound elastography diagnosis is possible (to date without clinical relevance), high-resolution MRI (used in scientific studies, without current clinical relevance).
Differential diagnoses:
Differential diagnosis of myalgia and musculoskeletal system diseases. Muscle and soft tissue tumors, primary and secondary myopathies, systemic neurological diseases, neurogenic dysfunctions, rheumatic diseases, hormonal disorders (e.g., hyperparathyroidism, hypothyroidism), medication side effects (e.g., lipid-lowering agents).
Dry needling, ischemic compression, acupuncture, stretching, electrotherapy, fascial release techniques, fascial therapies, infiltrations, muscle relaxation techniques, physiotherapy according to IMTT standards, thermotherapy (“Stretch and Spray”).
Indication:
Indicated by a specialist physician.
Before therapy:
Spatial requirements: Certification criteria for a medical practice, e.g., hygiene plan, emergency management available according to DIN standards.
Patient preparation: Positioning in a pain-free posture, structures to be treated must be easily accessible.
Information: Therapeutic pain also after treatment (in approximately 20–30%, similar to "muscle soreness"), if necessary, NSAID medication. Possible vegetative reaction (e.g., sweating, circulatory reactions).
Physician and assistant staff:
ESWT must be performed personally by a qualified physician with specialized expertise.
Contraindication:
Malignant tumor in the application area.
Therapy implementation:
Principle: Exact treatment of the myofascial trigger point at the point of pain with an intensity adapted to the pain (energy).
Documentation: Refer to the preamble. Specify the exact application of extracorporeal shockwave (ESW) therapy with anatomical localization (e.g., treated muscle or anatomical structure).
Criteria: Name the diagnostic criteria triggered during shockwave therapy: local pain, “recognition”, “referred pain” (feedback) and, where applicable, muscle twitch response.
Parameters: Specify the shockwave source, the number of impulses applied, and the intensity (EFD).
Post-treatment care:
Individual adjustment of loading, continuation of conservative therapies, stretching exercises and autonomous fascial treatment, physiotherapy.
STUDIES
Amelio E, Manganotti P: Effect of shockwave stimulation on hypertonic plantar flexor muscles in patients with cerebral palsy: a placebo-controlled study. J RehabilMed, 2010
Hausdorf J, Lemmens MA, Heck KD, et al. Selective loss of unmyelinated nerve fibers after extracorporeal shockwave application to the musculoskeletal system. Neuroscience. 2008Jul 31; 155(1):138-144.
Hong JO1, Park JS1, Jeon DG1, Yoon WH1, Park JH1. Extracorporeal Shock Wave Therapy Versus Trigger Point Injection in the Treatment of Myofascial Pain Syndrome in the Quadratus Lumborum. Ann Rehabil Med. 2017 Aug;41(4):582-588. doi: 10.5535/arm.2017.41.4.582. Epub 2017 Aug 31.
Jeon JH1, Jung YJ, Lee JY, Choi JS, Mun JH, Park WY, Seo CH, Jang KU. The effect of extracorporeal shockwave therapy on myofascial pain syndrome. Ann Rehabil Med. 2012 Oct;36(5):665-74. doi: 10.5535/arm.2012.36.5.665. epub 2012 Oct 31.
Ji HM, Kim HJ, Han SJ. Extracorporeal shockwave therapy in myofascial pain syndrome of upper trapezius. Ann Rehabil Med. 2012; 36:675-80.
M. Gleitz, K. Hornig, Trigger Points - Diagnosis and Treatment Concepts with Special Consideration of Extracorporeal Shock Waves Orthopade 41 (2012).
Kraus M, Reinhart E, Krause H, Reuther J. [Low energy extracorporeal shockwave therapy (ESWT) for treatment of myogelosis of the masseter muscle]. Mund Kiefer Gesichtschir.
1999; 3(1):20-3.
Lee JY, Kim SN, Lee IS, Jung H, Lee KS, Koh SE.
Effects of Extracorporeal Shock Wave Therapy on Spasticity in Patients after Brain Injury: A Meta-analysis J Phys Ther Sci. 2014 Oct;26(10):1641-7.
Lohse-Busch H, Kraemer M, Reime U.
[A pilot investigation into the effects of extracorporeal shockwaves on muscular dysfunction in children with spastic movement disorders].Pain. 1997 Apr 18;11(2):108-12.
Maier M, Averbeck B, Spleen S, Refior HJ, Schmitz C. Substance P and prostaglandin E2 release after shockwave application to the rabbit femur. Clin Orthop Relat Res. 2003 Jan 2003(406):237-245.
Manganotti P, Amelio E: Long-term effect of shockwave therapy on upper limb hypertonia in patients affected by stroke. Stroke, 2005
Mariotto S, Cavalieri E, Amelio E, et al: Extracorporeal shockwaves: from lithotripsy to anti-inflammatory action by NO production. Nitric Oxide, 2005
Mense S, Simons DG. Muscle pain: understanding its nature, diagnosis, and treatment.
Philadelphia: Lippincott Williams & Wilkins; 2001.
Moghtaderi A., Khosrawi S., Dehghan F. Extracorporeal shockwave therapy of gastroc-soleus trigger points in patients with plantar fasciitis: A randomized, placebo- controlled trial. Adv Biomed Res. 2014; 3: 99
Müller-Ehrenberg H, Licht G. Diagnosis and therapy of myofascial pain syndrome with focused shock waves (ESWT), Medizinisch Orthopädische Technik. 2005; 5:1-6.
Müller-Ehrenberg H, Thorwesten L, Pottebaum M, Epping H, Gries L, Völker K: Change in static and dynamic strength abilities after treatment of myofascial trigger points using focused ESWT for shoulder pain in sports, Sportärztekongress 2012 Frankfurt.
Schenk I, Vesper M, Nam VC. [Initial results using extracorporeal low energy shockwave therapy ESWT in muscle reflex-induced lock jaw]. Oral and Maxillofacial Surgery. 2002 Sep 2002; 6(5):351-355.
Ramon S, Gleitz M, Hernandez L, Romero LD Update on the efficacy of extracorporeal shockwave treatment for myofascial pain syndrome and fibromyalgia. International Journal of Surgery 24 (2015).
Shah JP, Danoff JV, Desai MJ, et al. Biochemicals associated with pain and inflammation are elevated in sites near to and remote from active myofascial trigger points. Arch Phys Med Rehabil. 2008 Jan; 89(1):16-23.
Travell J, D.G. S. Manual of muscle trigger points. Upper extremities, head, and thorax. 1 ed. Stuttgart: Gustav Fischer Verlag; 1998.
Travell J, D.G. S. Manual of muscle trigger points. Lower extremities and pelvis. 1ed. Munich: Urban & Fischer Verlag; 2000.
Wall PD, Cronly-Dillon JR. Pain, itch, and vibration. Arch Neurol. 1960 Apr 1960.